Weight loss medicines lead to 'Ozempic face'. A Korean biotech company now has a solution
Chief Executive Officer Lee Whan Chul said L&C Bio developed the technology around five years ago and holds patents in South Korea, the United States and China.
This article was aggregated from Business Today. Continue reading for the complete story.
Read on Business Today